Clinical Trials Logo

Fat Pad Syndrome clinical trials

View clinical trials related to Fat Pad Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT05880888 Recruiting - Fat Pad Syndrome Clinical Trials

Investigating the Clinical Impact of a Novel Adipose Allograft Matrix on Knee Fat Pad Impingement Treatment

Start date: April 22, 2023
Phase: Phase 1
Study type: Interventional

This study is to assess the effect of Renuva® on fat pad regeneration in patients with Fat pad Impingement

NCT ID: NCT04378270 Completed - Heel Pain Syndrome Clinical Trials

Validation of a Novel Foot Offloading Device

PopSole2
Start date: August 26, 2020
Phase: N/A
Study type: Interventional

Pressure offloading is often considered the most crucial aspect in healing after a foot injury. The investigators have devised a novel foot offloading device (PopSole™) which will allow for customization of the area where there is foot pain, as well as allow for customizable arch support and elevation of the metatarsals. This validation study is aimed to assess improvement of pain with use, ease of use, fit and feel, compliance, and durability over a 4 week period. Validated patient reported outcome measures will be used at baseline, 2 weeks and 4 weeks.

NCT ID: NCT04103866 Active, not recruiting - Metatarsalgia Clinical Trials

Pressure Offloading Injectible System With the Use of Juvederm Voluma in the Foot

POIS
Start date: November 1, 2019
Phase: N/A
Study type: Interventional

The current use of Juvederm Voluma XC is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21. In this particular setting, the intended use of the product Juvederm Voluma XC is to show that the filler works to alleviate stress in high pressure areas in the foot during gait, thus decreasing foot pain and allowing individuals to walk more comfortably.

NCT ID: NCT03873207 Withdrawn - Plantar Fascitis Clinical Trials

Offloading Device for Post Surgical Foot Procedures

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Study goals are to determine if a novel post-surgical foot offloading device can reduce post-operative pain and expedite the return to daily activity following fat grafting. Investigators will perform a prospective, randomized study utilizing PopSole™, a novel fully customizable post-operative shoe insert, to aid in the recovery of patients post-surgical fat graft injections for pain and limited activity due to foot disorders (ie. fat pad atrophy of the forefoot, heel, or for chronic plantar fasciitis). Standard of care fat grafting is often used in plastic surgery for cosmetic or reconstructive reasons. Foot fat grafting, though not considered part of this research trial, is routinely offered in the UPMC Aesthetic Plastic Surgery center as a cosmetic surgery option; however, treatment modality options following the completion of a foot fat grafting procedure to protect the fat grafts and reduce weight bearing on the fresh fat grafts are limited. Current standard of care options including crutches, scooters, bulky post-operative shoes (ie. Darco shoes [Darco Intl. Huntington WV.]), and the addition of padding to insoles or orthotics that attempt to offload the treated area. Most of these devices are flat and provide poor anatomical support, leading to compensatory gait issues which can lead to further problems and pain in the knees, hips, and back. The most common complication with post-operative foot gear is non-compliance: patients do not wear it. The investigators have devised a novel foot offloading device (PopSole™) which will allow for customization of the area where the fat has been injected into the foot, as well as allow for customizable arch support and elevation of the metatarsals. By randomizing patients to recovery with standard methods versus this new device, the investigators are hopeful for earlier patient ambulation and return to work with decreased pain.